| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ketobemidone | nmda receptor | small molecule | NA | drugbank | Fracture[MeSHID:D050723] Malignant Neoplasms[MeSHID:D009369] Kidney Calculi[MeSHID:D007669] Nephrolithiasis[MeSHID:D053040] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] |
NA | investigational | antagonist |
| ketobemidone | nmda receptor | small molecule | NA | drugbank | Fracture[MeSHID:D050723] Malignant Neoplasms[MeSHID:D009369] Kidney Calculi[MeSHID:D007669] Nephrolithiasis[MeSHID:D053040] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] |
NA | investigational | antagonist |
| ketobemidone | nmda receptor | small molecule | NA | drugbank | Fracture[MeSHID:D050723] Malignant Neoplasms[MeSHID:D009369] Kidney Calculi[MeSHID:D007669] Nephrolithiasis[MeSHID:D053040] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] |
NA | investigational | antagonist |
| ketobemidone | nmda receptor | small molecule | NA | drugbank | Fracture[MeSHID:D050723] Malignant Neoplasms[MeSHID:D009369] Kidney Calculi[MeSHID:D007669] Nephrolithiasis[MeSHID:D053040] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] |
NA | investigational | antagonist |
| ketobemidone | nmda receptor | small molecule | NA | drugbank | Fracture[MeSHID:D050723] Malignant Neoplasms[MeSHID:D009369] Kidney Calculi[MeSHID:D007669] Nephrolithiasis[MeSHID:D053040] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] |
NA | investigational | antagonist |
| ketobemidone | nmda receptor | small molecule | NA | drugbank | Fracture[MeSHID:D050723] Malignant Neoplasms[MeSHID:D009369] Kidney Calculi[MeSHID:D007669] Nephrolithiasis[MeSHID:D053040] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] |
NA | investigational | antagonist |
| ketobemidone | nmda receptor | small molecule | NA | drugbank | Fracture[MeSHID:D050723] Malignant Neoplasms[MeSHID:D009369] Kidney Calculi[MeSHID:D007669] Nephrolithiasis[MeSHID:D053040] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] |
NA | investigational | antagonist |
| ketobemidone | delta-type opioid receptor | small molecule | NA | drugbank | Fracture[MeSHID:D050723] Malignant Neoplasms[MeSHID:D009369] Kidney Calculi[MeSHID:D007669] Nephrolithiasis[MeSHID:D053040] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] |
NA | investigational | agonist |
| ketobemidone | kappa-type opioid receptor | small molecule | NA | drugbank | Fracture[MeSHID:D050723] Malignant Neoplasms[MeSHID:D009369] Kidney Calculi[MeSHID:D007669] Nephrolithiasis[MeSHID:D053040] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] |
NA | investigational | agonist |
| ketobemidone | mu-type opioid receptor | small molecule | NA | drugbank | Fracture[MeSHID:D050723] Malignant Neoplasms[MeSHID:D009369] Kidney Calculi[MeSHID:D007669] Nephrolithiasis[MeSHID:D053040] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] |
NA | investigational | agonist |
| click here to return to the previous page | ||||||||